Table of Contents Author Guidelines Submit a Manuscript

Complementary and Alternative Medicine for Diseases and Disorders in Digestive Tract: Basic to Clinics

Call for Papers

The digestive tract (also called as gastrointestinal tract, GI tract) is a long pathway about 9 meters long, passing through the longitudinal center of body from the mouth to the anus. GI tract also provides the ecosystem of bacterial flora which is importantly associated with health and various disease statuses. Accordingly, the disorders or diseases raised from GI tract are the commonly seen pathologic conditions in clinical practices. In addition, GI tract is the site that adverse-events are frequently observed by the majority of cancer-associated chemotherapy or radiotherapy.

We invite investigators to contribute original research as well as review articles of CAM focused on the GI tract disorders or diseases; esophagitis, dyspepsia, gastritis, gastric ulcer, abdominal pain, flatulence, nausea/vomiting, constipation, diarrhea, irritable bowel syndrome (IBS), Crohn’s disease, and side effects of chemotherapy or radiotherapy in digestive tract. Therapies of interest include acupuncture, moxibustion, cupping, herbal medicine, microbial therapy using probiotics, and other nonpharmacological interventions like massage, yoga, Qigong, or any “mind-body medicine.”

We are particularly interested in articles that explore the clinical or animal-based evidences for the effectiveness of CAM. Potential topics include, but are not limited to:

  • Complementary and alternative therapies for treating/managing GI tract disorders or diseases such as IBS or Crohn's disease
  • Complementary and alternative therapies for preventing any of GI tract disorders or diseases; evidenced especially from clinical study
  • Herbal drug/supplement study for any GI tract disorders or diseases using clinical trials or animal models
  • Human or animal studies exploring the mechanisms of CAM's therapies on GI motility disorders
  • Complementary and alternative therapies for reducing any of the adverse-events at GI tract caused by chemotherapy or radiotherapy
  • Microbial therapy for GI disease (including phage therapy and fecal transplant or probiotics)

Before submission authors should carefully read over the journal's Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

Manuscript DueFriday, 15 March 2013
First Round of ReviewsFriday, 7 June 2013
Publication DateFriday, 2 August 2013

Lead Guest Editor

  • Chang Gue Son, Liver & Immunology Research Center, Daejeon Oriental Hospital of Daejeon University, Daejeon, Republic of Korea

Guest Editors

  • Zhao Xiang Bian, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong
  • Jing Hua Wang, Key Laboratory of Xin'an Medicine of Ministry of Education, Clinical College of TCM, Anhui University of TCM, Anhui Province, Hefei, China
  • H. Balaji Raghavendran, Department of Orthopaedic Surgery, Faculty of Medicine, University of Malaya. 50603 Lembah Pantai, Kuala Lumpur, Malaysia